NYSE - Delayed Quote USD

Cencora, Inc. (COR)

237.95

+0.26

(+0.11%)

At close: 4:00 PM EDT

236.18

-1.77

(-0.74%)

After hours: 5:27 PM EDT

Here's Why Cencora (COR) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 9 days ago

COR
+0.11%
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.

Zacks 9 days ago

COR
+0.11%
AORT
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release

CONSHOHOCKEN, Pa., April 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 1, 2024.

Business Wire 19 days ago

COR
+0.11%
Are Medical Stocks Lagging Artivion (AORT) This Year?

Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.

Zacks 27 days ago

AORT

COR
+0.11%
Why Cencora (COR) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 28 days ago

COR
+0.11%
Cencora Announces Leadership Succession Plan

CONSHOHOCKEN, Pa., March 12, 2024--Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, current Chief Operating Officer of Cencora, will succeed Collis as President and CEO, and will also be appointed as a member of the Company's Board, effective the same date.

Business Wire last month

COR
+0.11%
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks last month

COR
+0.11%
Walgreens Boots pockets $992 million after cutting Cencora stake for third time

The proceeds include around $942 million from shares sold as well as about $50 million from a concurrent share repurchase by Cencora, formerly AmerisourceBergen. Walgreens has been grappling with waning demand for COVID-19 vaccines and testing as well as decreased spending on personal care and beauty products by inflation-weary consumers. It said it now owns around 13% of Cencora's common stock from 15% previously, and that it would use the sale proceeds primarily to pay down debt.

Reuters 2 months ago

WBA

COR
+0.11%
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.

Business Wire 2 months ago

COR
+0.11%
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds

DEERFIELD, Ill., February 07, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) common stock pursuant to Rule 144 for proceeds of approximately $942 million and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by Cencora in the amount of approximately $50 million.

Business Wire 2 months ago

COR
+0.11%
WBA
Cencora Closes $500 Million Senior Notes Offering

CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the "Notes"), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the "SEC") on November 23, 2021.

Business Wire 2 months ago

COR
+0.11%
Cencora Prices $500 Million 5.125% Senior Notes Due 2034

CONSHOHOCKEN, Pa., February 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the "Notes"), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the "SEC") on November 23, 2021. The offering is expected to close on February 7, 2024, subject to the satisfaction of customar

Business Wire 2 months ago

COR
+0.11%
Companies test out different ways to talk about ESG without saying 'ESG'

Mentions of ESG are falling again during this earnings season as bosses come up with different ways of talking about social responsibility and climate change.

Yahoo Finance 2 months ago

BLK

COR
+0.11%
JPM
Cencora Reports Fiscal 2024 First Quarter Results

CONSHOHOCKEN, Pa., January 31, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent year-over-year to $72.3 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.98 for the first quarter of fiscal 2024 compared to $2.33 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described

Business Wire 2 months ago

COR
+0.11%
Why Cencora (COR) Could Beat Earnings Estimates Again

Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks 2 months ago

COR
+0.11%
Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?

Cencora (COR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks 3 months ago

COR
+0.11%
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release

CONSHOHOCKEN, Pa., January 04, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2024 on Wednesday, January 31, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on January 31, 2024.

Business Wire 3 months ago

COR
+0.11%
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 4 months ago

COR
+0.11%
Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has entered into a distribution agreement with Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation.

PR Newswire 4 months ago

COR
+0.11%
Walgreens cuts Cencora stake further in $674 million share sale

After the share repurchase, Walgreens now owns approximately 15% in drug distributor Cencora, it said, adding that it would use the proceeds to pay down debt. AmerisourceBergen disclosed plans early this year to rename itself as Cencora in a bid to expand internationally beyond drug distribution.

Reuters 5 months ago

WBA

COR
+0.11%

Performance Overview

Return	COR	S&P 500
YTD	+16.11%	+6.33%
1-Year	+44.18%	+22.70%
3-Year	+102.93%	+21.33%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Cencora, Inc. (COR)

Here's Why Cencora (COR) is a Strong Value Stock

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release

Are Medical Stocks Lagging Artivion (AORT) This Year?

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Cencora Announces Leadership Succession Plan

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Walgreens Boots pockets $992 million after cutting Cencora stake for third time

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds

Cencora Closes $500 Million Senior Notes Offering

Cencora Prices $500 Million 5.125% Senior Notes Due 2034

Companies test out different ways to talk about ESG without saying 'ESG'

Cencora Reports Fiscal 2024 First Quarter Results

Why Cencora (COR) Could Beat Earnings Estimates Again

Cencora, Inc. (COR) Hits Fresh High: Is There Still Room to Run?

Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

Walgreens cuts Cencora stake further in $674 million share sale

Performance Overview